38 CFR § 4.100 - Application of the general rating formula for diseases of the heart.
---
identifier: "/us/cfr/t38/s4.100"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "38 CFR § 4.100 - Application of the general rating formula for diseases of the heart."
title_number: 38
title_name: "Pensions, Bonuses, and Veterans' Relief"
section_number: "4.100"
section_name: "Application of the general rating formula for diseases of the heart."
chapter_name: "DEPARTMENT OF VETERANS AFFAIRS"
part_number: "4"
part_name: "SCHEDULE FOR RATING DISABILITIES"
positive_law: false
currency: "2026-03-24"
last_updated: "2026-03-24"
format_version: "1.1.0"
generator: "[email protected]"
authority: "38 U.S.C. 1155, unless otherwise noted."
regulatory_source: "29 FR 6718, May 22, 1964, unless otherwise noted."
cfr_part: "4"
---
# 4.100 Application of the general rating formula for diseases of the heart.
(a) Whether or not cardiac hypertrophy or dilatation (documented by electrocardiogram, echocardiogram, or X-ray) is present and whether or not there is a need for continuous medication must be ascertained in all cases.
(b) Even if the requirement for a 10% (based on the need for continuous medication) or 30% (based on the presence of cardiac hypertrophy or dilatation) evaluation is met, METs testing is required in all cases except:
(1) When there is a medical contraindication.
(2) When a 100% evaluation can be assigned on another basis.
(Authority: 38 U.S.C. 1155)
[71 FR 52460, Sept. 6, 2006, as amended at 86 FR 54093, Sept. 30, 2021; 86 FR 67654, Nov. 29, 2021]